Photobiomodulation Modulates the Response of Zoledronic-Acid-Treated Osteoblast-like SaOs-2 Cells: Implications for Bisphosphonate-Related Osteonecrosis. [PDF]
Andraus RAC +14 more
europepmc +1 more source
Effect of Zoledronic Acid Administration Timing on Metastatic Bone Tumors. [PDF]
Watanabe M +9 more
europepmc +1 more source
Retraction: Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption. [PDF]
PLOS One Editors.
europepmc +1 more source
Efficacy and Safety of Percutaneous Kyphoplasty Combined With Zoledronic Acid for Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis. [PDF]
Tayyab M +9 more
europepmc +1 more source
The Mitigating Effect and Mechanism of Polydeoxyribonucleotide Against Zoledronic Acid-Induced Growth Suppression of Human Gingival Fibroblasts. [PDF]
Pachhapure S +6 more
europepmc +1 more source
Effect of Zoledronic Acid on Skeletal Muscle After Bariatric Surgery: A Secondary Analysis From a Randomized Controlled Trial. [PDF]
Gam S +4 more
europepmc +1 more source
Comparative Efficacy and Cost-Effectiveness of Denosumab Versus Zoledronic Acid in Cancer Patients with Bone Metastases. [PDF]
Aliyev V +9 more
europepmc +1 more source
Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441]. [PDF]
Yue J, Sun W, Li S.
europepmc +1 more source
Efficacy, safety and economy of denosumab and zoledronic acid in the treatment of bone metastases of solid tumors and multiple myeloma: a systematic review and meta-analysis. [PDF]
Zhong L +9 more
europepmc +1 more source
Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis. [PDF]
Iwai C +6 more
europepmc +1 more source

